High Expression of JMJD4 Is a Potential Diagnostic and Prognostic Marker of Renal Cell Carcinoma

Table 1

Clinical characteristics of ccRCC patients.

Characteristic	Levels	Overall
		539
T stage, (%)	T1	278 (51.6%)
	T2	71 (13.2%)
	T3	179 (33.2%)
	T4	11 (2%)
N stage, (%)	N0	241 (93.8%)
	N1	16 (6.2%)
M stage, (%)	M0	428 (84.6%)
	M1	78 (15.4%)
Pathologic stage, (%)	Stage I	272 (50.7%)
	Stage II	59 (11%)
	Stage III	123 (22.9%)
	Stage IV	82 (15.3%)
Primary therapy outcome, (%)	PD	11 (7.5%)
	SD	6 (4.1%)
	PR	2 (1.4%)
	CR	128 (87.1%)
Gender, (%)	Female	186 (34.5%)
	Male	353 (65.5%)
Race, (%)	Asian	8 (1.5%)
	Black or African American	57 (10.7%)
	White	467 (87.8%)
Age, (%)	≤60	269 (49.9%)
	>60	270 (50.1%)
Histologic grade, (%)	G1	14 (2.6%)
	G2	235 (44.3%)
	G3	207 (39%)
	G4	75 (14.1%)
Age, median (IQR)		61 (52, 70)